In this regard, it is noteworthy that several factors with proven anti-lymphangiogenic activity, such as transforming growth factor-β1, thrombospondin, and endostatin, are known to be increased and to have pathogenic implications in SSc [1,6,14,23,29,44,45,46,47,48]. Here, COL18A1 is linked to systemic sclerosis.